Search Results - "Garovoy, M."

Refine Results
  1. 1

    A Phase I/II Randomized Open‐Label Multicenter Trial of Efalizumab, a Humanized Anti‐CD11a, Anti‐LFA‐1 in Renal Transplantation by Vincenti, F., Mendez, R., Pescovitz, M., Rajagopalan, P. R., Wilkinson, A. H., Butt, K., Laskow, D., Slakey, D. P., Lorber, M. I., Garg, J. P., Garovoy, M.

    Published in American journal of transplantation (01-07-2007)
    “…Leukocyte function associated antigen‐1 (LFA‐1) has a multifaceted role in the immune response, including adhesion and trafficking of leukocytes, stabilizing…”
    Get full text
    Journal Article
  2. 2

    A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis by Lebwohl, Mark, Tyring, Stephen K, Hamilton, Tiffani K, Toth, Darryl, Glazer, Scott, Tawfik, Naji H, Walicke, Patricia, Dummer, Wolfgang, Wang, Xiaolin, Garovoy, Marvin R, Pariser, David

    Published in The New England journal of medicine (20-11-2003)
    “…Leukocyte-function–associated antigen type 1 (LFA-1) is involved in the pathogenesis of psoriasis. Efalizumab is a humanized monoclonal antibody that binds to…”
    Get full text
    Journal Article
  3. 3

    Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis by Bauer, R J, Dedrick, R L, White, M L, Murray, M J, Garovoy, M R

    “…The pharmacokinetics of hu1124, a human anti-CD11a antibody, were investigated in human subjects with psoriasis. CD11a is a subunit of LFA-1, a cell surface…”
    Get full text
    Journal Article
  4. 4

    HLA class II antigen associations help to define two types of alopecia areata by COLOMBE, B. W, PRICE, V. H, KHOURY, E. L, GAROVOY, M. R, LOU, C. D

    “…Multiple HLA class I and class II antigen associations have been described for alopecia areata (AA). As in other immune-mediated diseases, the HLA antigens…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Thrombin stimulates c-sis gene expression in microvascular endothelial cells by Daniel, T O, Gibbs, V C, Milfay, D F, Garovoy, M R, Williams, L T

    Published in The Journal of biological chemistry (25-07-1986)
    “…We have determined whether expression of the c-sis gene product, platelet-derived growth factor (PDGF), is regulated in cultured renal microvascular…”
    Get full text
    Journal Article
  7. 7

    IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells by Martinez, OM, Gibbons, RS, Garovoy, MR, Aronson, FR

    Published in The Journal of immunology (1950) (15-03-1990)
    “…Recent studies have shown that IL-4 can affect lymphocyte responses to IL-2. To evaluate the effects of IL-4 on T cell responses to physiologically relevant…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Successful immunomodulation with intravenous gamma globulin and cyclophosphamide in an alloimmunized heart transplant recipient by De Marco, T, Damon, L E, Colombe, B, Keith, F, Chatterjee, K, Garovoy, M R

    “…A highly human leukocyte antigen-sensitized heart transplant candidate underwent immunomodulation with intravenous gamma globulin and cyclophosphamide. His…”
    Get more information
    Journal Article
  10. 10

    Characteristics of Oligonucleotide Uptake in Human Keratinocyte Cultures by Noonberg, Sarah B, Garovoy, Marvin R, Hunt, C Anthony

    Published in Journal of investigative dermatology (01-11-1993)
    “…Oligodeoxyribonucleotides have the potential to interfere selectivity with cellular protein synthesis by sequence-specific hybridization to DNA or RNA…”
    Get full text
    Journal Article
  11. 11

    Cytokine and T cell receptor gene expression at the site of allograft rejection by Krams, S M, Falco, D A, Villanueva, J C, Rabkin, J, Tomlanovich, S J, Vincenti, F, Amend, W J, Melzer, J, Garovoy, M R, Roberts, J P

    Published in Transplantation (01-01-1992)
    “…Intragraft cytokine and T cell receptor gene expression was analyzed in rejecting renal allografts by polymerase chain reaction (PCR). Message for IL-1 beta,…”
    Get more information
    Journal Article
  12. 12

    Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration by Gupta, S K, Manfro, R C, Tomlanovich, S J, Gambertoglio, J G, Garovoy, M R, Benet, L Z

    Published in Journal of clinical pharmacology (01-07-1990)
    “…The pharmacokinetics of cyclosporine were studied in healthy subjects following administration of cyclosporine both orally (10 mg kg-1) and intravenously (4 mg…”
    Get more information
    Journal Article
  13. 13

    Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants by O'rourke, Robert W, Osorio, Robert W, Freise, Chris E, Lou, Calvin D, Garovoy, Marvin R, Bacchetti, Peter, Ascher, Nancy L, Melzer, Juliet S, Roberts, John P, Stock, Peter G

    Published in Clinical transplantation (01-04-2000)
    “…Flow cytometry crossmatching (FCXM) was developed as a more sensitive assay than the standard complement‐dependent cytotoxicity crossmatch (CDCXM) for the…”
    Get full text
    Journal Article
  14. 14

    The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities by Kiprov, D D, Nachtigall, R D, Weaver, R C, Jacobson, A, Main, E K, Garovoy, M R

    “…Several studies have evaluated the effect of intravenous gammaglobulin (IVIG) in women with unexplained recurrent spontaneous abortions (RSA). Data regarding…”
    Get more information
    Journal Article
  15. 15

    Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation by Popov, I A, Fedoseyeva, E V, Orr, P L, Garovoy, M R, Benichou, G

    Published in Transplantation (27-12-1995)
    “…There is accumulating evidence indicating that the T cell response to donor major histocompatibility complex (MHC) peptides plays a crucial role in graft…”
    Get more information
    Journal Article
  16. 16

    Identification of high- and low-risk second kidney grafts by MAHONEY, R. J, NORMAN, D. J, COLOMBE, B. W, GAROVOY, M. R, LEEBER, D. A

    Published in Transplantation (15-05-1996)
    “…The purpose of this study was to identify recipients who are at low or high risk of early cadaveric regraft failure by segregating results of the flow…”
    Get full text
    Journal Article
  17. 17

    Induction of T cell responses to a self-antigen following allotransplantation by FEDOSEYEVA, E. V, TAM, R. C, POPOV, I. A, ORR, P. L, GAROVOY, M. R, BENICHOU, G

    Published in Transplantation (15-03-1996)
    “…T cell tolerance to self-antigens is established through the recognition by immature T cells of dominant self-peptides presented in association with self-MHC…”
    Get full text
    Journal Article
  18. 18

    Long-term engraftment following in utero T cell-depleted parental marrow transplantation into fetal rhesus monkeys by Cowan, M J, Tarantal, A F, Capper, J, Harrison, M, Garovoy, M

    Published in Bone marrow transplantation (Basingstoke) (01-06-1996)
    “…A major concern with allogeneic BMT for treating most inherited diseases is the need to overcome graft rejection with conditioning chemotherapy which is…”
    Get more information
    Journal Article
  19. 19
  20. 20

    An oligonucleotide blocks interferon-γ signal transduction by LEE, P. P, RAMANATHAN, M, HUNT, C. A, GAROVOY, M. R

    Published in Transplantation (15-11-1996)
    “…Interferon (IFN)-gamma is an important mediator of transplant graft rejection. It induces endothelial cell expression of HLA-DR and intercellular adhesion…”
    Get full text
    Journal Article